FDA Closes Potential Food Additive Option In Warnings To Supplement Firms
Six warnings to firms marketing products containing DMHA mark a change in the agency's supplement market oversight with explanation that non-dietary ingredients that have not been approved for use in food are deemed unsafe and are not allowed for use in supplements under an exemption for food additives Other three firms FDA warned were advised the ingredient phenibut found in their products also isn't eligible for use in supplements.
You may also be interested in...
Warning doesn't reference any noncompliant claims for CBD-labeled Green Roads, but FDA explains the basis for which it has stated for two years it could warn every firm marketing products that are labeled as or found containing CBD.
UK pharma announced that in 2021 it will close its manufacturing facility in Carlisle, PA, where around 260 people are employed making the Emergen-C line. It will move the manufacturing to its Guayama, PR, facility.